IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.00
Bid: 66.00
Ask: 68.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.03%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 67.00
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Blencowe And BlueRock Recommence Operations

Mon, 11th May 2020 12:03

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Monday and not separately reported by Alliance News:

----------

Open Orphan PLC - pharmaceutical services - Subsidiary hVIVO enters contract with Nasdaq-listed diagnostics firm Quotient to use MosaiQ system and MosaiQ Covid-19 antibody microarray to screen for SARS-CoV-2 antibodies, which is produced when humans are infected with Covid-19.

----------

Avacta Group PLC - biotherapeutics - To ship Affimer reagents for the development of a point-of-care saliva-based Covid-19 antigen test strip by Cytiva, for CE Marking in Europe and US Food & Drug Administration approval. Will also be sent to Adeptrix, which is developing Covid-19 laboratory test to run on hospital mass spectrometers.

----------

BlueRock Diamonds PLC - diamonds - Recommences operations at Kareevlei diamond mine in Kimberley, South Africa. Expects to start operations at full capacity by the end of May, but expansion plans on hold.

----------

Chesterfield Resources PLC - mineral exploration - Plans to resume drilling operations on its Troodos West licences by mid-June, following government of Cyprus providing a detailed four-phase roadmap out of lockdown, which is spread over the next two months up until July 14.

----------

Blencowe Resources PLC - mining - Recommences key metallurgical test work on Orom-Cross graphite project in Uganda, after being on hold for six weeks since late March due to lockdown. Due to restart 59-hole diamond drilling programme, which is designed to deliver a maiden JORC resource during the middle of 2020.

----------

Phoenix Spree Deutschland Ltd - real estate - Rent collection for April at 98% compared to 99% in January. Refinances EUR16.4 million in debt acquired as part of acquisition of Brandenburg apartment complex. Will pay second dividend of 5.15 cents per share, remain confident in long-term outlook.

----------

Petro Matad Ltd - Mongolian oil explorer - Executive directors, non-executive directors and senior managers to take salary cut averaging 50%, backdated to the start of second quarter of 2020. Professional advisers to reduce its fees by up to 45%. To focus on securing Block XX exploitation licence and retaining its Block V exploitation licence.

----------

Anglo African Agriculture PLC - agriculture investment - Trading subsidiary Dynamic Intertrade remains fully operational despite South Africa lockdown, due to providing essential services as a food manufacturer. Expects revenue for six months ending October 31 to double year-on-year. Progress with Comarco transaction protracted due to general market environment.

----------

iEnergizer Ltd - media and technology services - Continues to trade effectively in lockdown imposed by government of India. Business operating at 80% to 90% efficiency to its clients. Balance sheet, net cash position and long-term customer relationships remain strong.

----------

Cake Box Holdings PLC - cakes retailer - Following initial trial of limited number of stores operating Click & Collect service and delivery in partnership, now has 79 franchise stores open, offering a limited menu of products. Expects to have full high street estate open by early June.

----------

Midwich Group PLC - audio-visual distributor - Delivered strong performance in 2019, with growth in revenue and rise in profit. Challenging trading conditions over the past two months, expected to continue until lockdown conditions in Europe and North America are "significantly eased".

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
10 Oct 2019 08:39

Avacta inks collaboration deal with ADC Therapeutics

(Sharecast News) - Biotechnology company Avacta Group has entered a collaboration and option agreement with ADC Therapeutics, which it described as a Switzerland-based clinical-stage oncology-focused biotechnology company pioneering the development of "highly potent and targeted" antibody-drug conjugates for patients suffering from haematological malignancies and solid tumours.

Read more
20 Jun 2019 10:28

Avacta partners with Selexis ahead of first-in-human trials

(Sharecast News) - Avacta Group announced on Thursday that it has partnered with life sciences company Selexis to develop the Chinese hamster ovary (CHO) cell line, which will be used to manufacture Avacta's first 'Affimer' clinical candidate for first-time-in-human clinical trials.

Read more
10 Jun 2019 10:51

Avacta Selects Candidate For First Human Trials Of Affimer Platform

LONDON (Alliance News) - Avacta Group PLC on Monday said it has selected a clinical development candidate AVA004 for first-time-in-human clinical trials of its Affimer platform.Affimer an a

Read more
3 Jun 2019 10:20

Avacta To Submit Application For TMAC Linker Testing In Tumours Study

LONDON (Alliance News) - Avacta Group PLC on Monday said it is planning to submit an application to test its TMAC linker in patients with selected solid tumours in early 2020.The company, a

Read more
9 Apr 2019 12:11

Avacta falls as stuttering revenues exacerbate losses

(Sharecast News) - Avacta Group's shares slid on Tuesday as interim revenues dropped on the back of a lower contribution from the life sciences division, which resulted in wider losses.

Read more
9 Apr 2019 10:37

Avacta shares fall as interim revenues slide

(Sharecast News) - Biotherapeutics and research reagents developer Avacta Group reported a fall in half-year revenues to £1.0m on Tuesday, from £1.5m a year earlier.

Read more
9 Apr 2019 09:49

Avacta Shares Fall On Widened Interim Loss, Lower Revenue

LONDON (Alliance News) - Avacta Group PLC on Tuesday reported a widened first half loss mainly due to lower income contribution from life sciences unit.The stock was trading 8.5% lower on a

Read more
28 Jan 2019 12:01

Avacta Hires IP Group Unit Boss Sam Williams As Non-Executive Director

LONDON (Alliance News) - Avacta Group PLC on Monday said it has appointed Sam Williams as a non-executive director with immediate effect.The biotechnology company said Williams is currently

Read more
21 Jan 2019 12:14

Avacta Group makes solid development progress

(Sharecast News) - Biotherapeutics developer Avacta Group updated the market on its trading on Monday, as investors gathered for its annual general meeting.

Read more
3 Jan 2019 11:34

IP Group Builds Over 17% Holding In Biotechnology Firm Avacta (ALLISS)

LONDON (Alliance News) - Avacta Group PLC on Thursday said IP Group PLC now holds 17.2% stake in the biotechnology company following a transaction on December 18.Prior to that, IP holding

Read more
12 Dec 2018 11:14

Avacta Group Appoints Roche's Jose Saro As Chief Medical Officer

LONDON (Alliance News) - Reagents developer Avacta Group PLC on Wednesday appointed Jose Saro as chief medical officer to lead the firm's therapeutic development strategy.Saro brings 20

Read more
12 Dec 2018 09:45

Avacta Group picks up Jose Saro as chief medical officer

(Sharecast News) - Biotherapeutic development company Avacta Group announced on Wednesday that Dr Jose Saro has been appointed as its chief medical officer, to lead its therapeutic development strategy and drive the in-house programmes into the clinic.

Read more
10 Dec 2018 08:52

IP Group Investee Teams With LG Chem To Develop Affimer Drug Candidate

LONDON (Alliance News) - IP Group PLC on Monday said its portfolio company Avacta Group PLC signed a development & license deal with LG Chem Life Sciences.IP Group currently holds a in

Read more
10 Oct 2018 16:33

Avacta 'delighted' at license agreement with longtime collaborator

(Sharecast News) - Avacta Group agreed a commercial license with New England Biolabs (NEB) to commercialise a science and research assay project using its Affimer technology on Wednesday.

Read more
2 Oct 2018 15:23

Avacta hails progress on in-house and third-party programmes

(Sharecast News) - Avacta Group posted a slightly wider full-year loss on Wednesday even as it highlighted progress both with its in-house programmes and third parties.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.